Acrivon Therapeutics
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $100M
Investors
- 12
About Acrivon Therapeutics
Based in Massachusetts, US, and founded in 2018 by its CEO, Peter Blume-Jensen, and co-founder Kristina Masson, Acrivon Therapeutics, Inc. operates as a clinical-stage oncology therapeutics company that uses the Predictive Precision Proteomics (AP3) technology platform to help reduce toxicity by developing chemically designed drugs by matching patients with the active disease-driving processes of cancer. In November 2021, Acrivon Therapeutics, Inc. Acrivon Therapeutics, Inc. leverages its proprietary phosphoproteomics technology, called Acrivon Precision Predictive Proteomics, in the development of its pipeline of oncology drugs. The AP3 platform enables the creation of drug-specific proprietary OncoSignature®. Acrivon Therapeutics, Inc.
Who invested in Acrivon Therapeutics
12 investors across 1 round
See all investors in Acrivon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 9, 2021
Amount
$100M
Investors
Questions about Acrivon Therapeutics
Who invested in Acrivon Therapeutics?
Acrivon Therapeutics has 12 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acrivon Therapeutics raised?
Acrivon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Acrivon Therapeutics last raise money?
Acrivon Therapeutics's most recent round on record is a Series B, in Nov 2021.
What does Acrivon Therapeutics do?
Based in Massachusetts, US, and founded in 2018 by its CEO, Peter Blume-Jensen, and co-founder Kristina Masson, Acrivon Therapeutics, Inc.
Where is Acrivon Therapeutics headquartered?
Acrivon Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Acrivon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Acrivon Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Acrivon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.